Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1α/β released from neutrophils recruited by mast cell-derived TNFα

Blood

Volumn 101, Issue 1, 2003, Pages 210-215

  Von Stebut, Esther ^a,b   Metz, Martin ^a,b   Milon, Genevieve ^a,b   Knop, Jörgen ^a,b   Maurer, Marcus ^a,b,c  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b INSTITUT PASTEUR   (France)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; POLYACRYLAMIDE GEL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GRANULOMA; INFLAMMATION; MACROPHAGE MIGRATION; MACROPHAGE MIGRATION INHIBITION; MAST CELL; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 0037220342     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0921     Document Type: Article

References (31)

1. Schaible UE, Collins HL, Kaufmann SH. Confrontation between intracellular bacteria and the immune system. Adv Immunol. 1999;71:267-377.
2. Belkaid Y, Mendez S, Lira R, Kadambi N, Sacks DL, A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol. 2000;165:969-977.
3. Murray HW. Tissue granuloma structure-function in experimental visceral leishmaniasis. Int J Exp Pathol. 2001;82:249-267.
4. Lamendola MG. Invasive aspergillosis: Description of a case in an infant with severe granulocytopenia and endocardial fibroelastosis. Pathologica. 1997;89:432-440.
5. Echtenacher B, Männel DN, Hültner L. Critical protective role of mast cells in a model of acute septic peritonitis. Nature. 1996;381:75-77.
6. Malaviya R, Ikeda T, Abraham SN. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha. Nature. 1996;381:77-80.
7. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature. 1997;390:172-175.
8. Maurer M, Echtenacher B, Hültner L, et al. The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells. J Exp Med. 1998;188:2343-2348.
9. Gordon JR. Monocyte chemoattractant peptide-1 expression during cutaneous allergic reactions in mice is mast cell dependent and largely mediates the monocyte recruitment response. J Allergy Clin Immunol. 2000;106:110-116.
10. Tang T, Jennings TA, Eaton JW. Mast cell mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A. 1998;95:8841-8846.
11. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G. Immune and inflammatory responses in TNF alpha-deficient mice: A critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J Exp Med. 1996;184:1397-1411.
12. Fauve RM, Jusforgues H, Hevin B. Maintenance of granuloma macrophages in serum-free medium. J Immunol Methods. 1983;64:345-351.
13. Harris RR, Wilcox D, Bell RL, Carter GW. The role of tissue mast cells in polyacrylamide gel-induced inflammation in mice. Inflamm Res. 1998;47:104-108.
14. von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: Implications for the initiation of anti-Leishmania immunity. J Exp Med. 1998;188:1547-1552.
15. Belkaid Y, Butcher B, Sacks DL. Analysis of cytokine production by inflammatory mouse macrophages at the single-cell level: Selective impairment of IL-12 induction in Leishmania-infected cells. Eur J Immunol. 1998;28:1389-1400.
16. + Th2 response in BALB/c mice infected with Leishmania major. J Immunol. 2000;165:2628-2636.
17. Boesiger J, Tsai M, Maurer M, et al. Mast cells can secrete vascular permeability factor/vascular endothelial cell growth factor and exhibit enhanced release after immunoglobulin E-dependent upregulation of Fc epsilon receptor I expression. J Exp Med. 1998;188:1135-1145.
18. Wershil BK, Murakami T, Galli SJ. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response: Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol. 1988;140:2356-2360.
19. Galli SJ, Maurer M, Lantz CS. Mast cells as sentinels of innate immunity. Curr Opin Immunol. 1999;11:53-59.
20. Chensue SW, Otterness IG, Higashi GI, Forsch CS, Kunkel SL. Monokine production by hyper-sensitivity (Schistosoma mansoni egg) and foreign body (Sephadex bead)-type granuloma macrophages: Evidence for sequential production of IL-1 and tumor necrosis factor. J Immunol. 1989;142:1281-1286.
21. Benini J, Ehlers EM, Ehlers S. Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent Mycobacterium avium. J Pathol. 1999;189:127-137.
22. Kindler V, Sappino AP, Grau GE, Piguet PF, Vassalli P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 1989;56:731-740.
23. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000;173:131-140.
24. Biedermann T, Kneilling M, Mailhammer R, et al. Mast cells control neutrophil recruitment during T cell-mediated delayed-type hypersensitivity reactions through tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med. 2000;192:1441-1452.
25. Lapinet JA, Scapini P, Calzetti F, Perez O, Cassatella MA. Gene expression and production of tumor necrosis factor alpha, interleukin-1 beta (IL-1beta), IL-8, macrophage inflammatory protein 1alpha (MIP-1alpha), MIP-1beta, and gamma interferon-inducible protein 10 by human neutrophils stimulated with group B meningococcal outer membrane vesicles. Infect Immun. 2000;68:6917-6923.
26. Luster AD. Chemokines - Chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445.
27. Wershil BK, Theodos CM, Gaili SJ, Titus RG. Mast cells augment lesion size and persistence during experimental Leishmania major infection in the mouse. J Immunol. 1994;152:4563-4571.
28. Bidri M, Vouldoukis I, Mossalayi MD, et al. Evidence for direct interaction between mast cells and Leishmania parasites. Parasite Immunol. 1997;19:475-483.
29. Luger TA, Brzoska T, Scholzen TE, et al. The role of alpha-MSH as a modulator of cutaneous inflammation. Ann N Y Acad Sci. 2000;917:232-238.
30. Zhang Y, Ramos BF, Jakschik BA. Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis. Science. 1992;258:1957-1959.
31. Tintinger GR, Theron AJ, Steel HC, Anderson R. Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease. Clin Exp Immunol. 2001;123:254-263.